Cargando…
The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation
Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myel...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932735/ https://www.ncbi.nlm.nih.gov/pubmed/20824059 http://dx.doi.org/10.1371/journal.pone.0012550 |
_version_ | 1782186098112331776 |
---|---|
author | Azuma, Masahiro Sawahata, Ryoko Akao, Yuusuke Ebihara, Takashi Yamazaki, Sayuri Matsumoto, Misako Hashimoto, Masahito Fukase, Koichi Fujimoto, Yukari Seya, Tsukasa |
author_facet | Azuma, Masahiro Sawahata, Ryoko Akao, Yuusuke Ebihara, Takashi Yamazaki, Sayuri Matsumoto, Misako Hashimoto, Masahito Fukase, Koichi Fujimoto, Yukari Seya, Tsukasa |
author_sort | Azuma, Masahiro |
collection | PubMed |
description | Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S-[2,3-bis(palmitoyl)propyl]cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-γ production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation. |
format | Text |
id | pubmed-2932735 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-29327352010-09-07 The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation Azuma, Masahiro Sawahata, Ryoko Akao, Yuusuke Ebihara, Takashi Yamazaki, Sayuri Matsumoto, Misako Hashimoto, Masahito Fukase, Koichi Fujimoto, Yukari Seya, Tsukasa PLoS One Research Article Natural killer (NK) cells are lymphocyte effectors that are activated to control certain microbial infections and tumors. Many NK-activating and regulating receptors are involved in regulating NK cell function. In addition, activation of naïve NK cells is fundamentally triggered by cytokines or myeloid dendritic cells (mDC) in various modes. In this study, we synthesized 16 S-[2,3-bis(palmitoyl)propyl]cysteine (Pam2Cys) lipopeptides with sequences designed from lipoproteins of Staphylococcus aureus, and assessed their functional properties using mouse (C57BL/6) bone marrow-derived DC (BMDC) and NK cells. NK cell activation was evaluated by three criteria: IFN-γ production, up-regulation of NK activation markers and cytokines, and NK target (B16D8 cell) cytotoxicity. The diacylated lipopeptides acted as TLR2 ligands, inducing up-regulation of CD25/CD69/CD86, IL-6, and IL-12p40, which represent maturation of BMDC. Strikingly, the Pam2Cys lipopeptides induced mouse NK cell activation based on these criteria. Cell-cell contact by Pam2Cys peptide-stimulated BMDC and NK cells rather than soluble mediators released by stimulated BMDC induced activation of NK cells. For most lipopeptides, the BMDC TLR2/MyD88 pathway was responsible for driving NK activation, while some slightly induced direct activation of NK cells via the TLR2/MyD88 pathway in NK cells. The potential for NK activation was critically regulated by the peptide primary sequence. Hydrophobic or proline-containing sequences proximal to the N-terminal lipid moiety interfered with the ability of lipopeptides to induce BMDC-mediated NK activation. This mode of NK activation is distinctly different from that induced by polyI:C, which is closely associated with type I IFN-inducing pathways of BMDC. These results imply that the MyD88 pathway of BMDC governs an alternative NK-activating pathway in which the peptide sequence of TLR2-agonistic lipopeptides critically affects the potential for NK activation. Public Library of Science 2010-09-02 /pmc/articles/PMC2932735/ /pubmed/20824059 http://dx.doi.org/10.1371/journal.pone.0012550 Text en Azuma et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Azuma, Masahiro Sawahata, Ryoko Akao, Yuusuke Ebihara, Takashi Yamazaki, Sayuri Matsumoto, Misako Hashimoto, Masahito Fukase, Koichi Fujimoto, Yukari Seya, Tsukasa The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title | The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title_full | The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title_fullStr | The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title_full_unstemmed | The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title_short | The Peptide Sequence of Diacyl Lipopeptides Determines Dendritic Cell TLR2-Mediated NK Activation |
title_sort | peptide sequence of diacyl lipopeptides determines dendritic cell tlr2-mediated nk activation |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2932735/ https://www.ncbi.nlm.nih.gov/pubmed/20824059 http://dx.doi.org/10.1371/journal.pone.0012550 |
work_keys_str_mv | AT azumamasahiro thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT sawahataryoko thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT akaoyuusuke thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT ebiharatakashi thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT yamazakisayuri thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT matsumotomisako thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT hashimotomasahito thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT fukasekoichi thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT fujimotoyukari thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT seyatsukasa thepeptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT azumamasahiro peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT sawahataryoko peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT akaoyuusuke peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT ebiharatakashi peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT yamazakisayuri peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT matsumotomisako peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT hashimotomasahito peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT fukasekoichi peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT fujimotoyukari peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation AT seyatsukasa peptidesequenceofdiacyllipopeptidesdeterminesdendriticcelltlr2mediatednkactivation |